How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?

Journal of Medical Screening

Volumn 20, Issue 2, 2013, Pages 99-103

  Castanon, Alejandra ^a   Landy, Rebecca ^a   Sasieni, Peter ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; INCIDENCE; MASS SCREENING; MIDDLE AGED; PAPILLOMA VIRUS; PATHOGENICITY; STATISTICS; UTERINE CERVIX TUMOR; VAGINA SMEAR; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS;

ADULT; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84890220919     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141313492313     Document Type: Article

References (13)

1. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-257
2. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009;124:516-520
3. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-1101
4. Mesher D, Szarewski A, Cadman L, Cubie H, Kitchener H, Luesley D, et al. Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer 2010;102:1405-1410
5. Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 2011;47:864-871
6. Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, et al. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study. Int J Cancer 2008;122:2294-2300
7. Wise J. Pilot study will assess whether HPV test should replace smears to screen for cervical cancer. BMJ 2012;344:e3744
8. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93
9. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26(Suppl 10):K29-K41
10. Office for National Statistics. Cancer statistics registrations. Registrations of cancer diagnosed in 2010, England. Series MB1 no. 41, London: 2012. Available from: http://www.ons.gov.uk/ons/publications/index.html?pageSize=50&newquery=Cancer+Statistics+Registrations%2C+England+(Series+MB1)&sortBy=pubdate&sortDirection=DESCENDING&content-type=publicationContentTypes&pubdateRangeType=
11. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368-383
12. Hendry M, Pasterfield D, Lewis R, Clements A, Damery S, Neal RD, et al. Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing. Br J Cancer 2012;107:243-254
13. Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, et al. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess 2009;13:1-150, iii-iv